Assisted NC businesses in winning 2,749 contracts valued up to $30.94 billion

2018 MBB SESSION SUMMARIES

Military Operational Medicine: Requirements and Acquisition Processes for Medical Products, Services, Education, Training and Research & Development.  Representatives of US Army Special Operations Command (USASOC), Womack Army Medical Center, US Army Medical Materiel Agency, Naval Hospital Camp Lejeune and Navy Medicine East will identify current and future requirements and needs for medical products and services, and will outline the processes they use to acquire these products and services. Businesses with the capability to support the special operations community should participate in this interactive session.

  • Lieutenant Colonel Stephen M. DeLellis MPAS, PA-C, Deputy Surgeon, US Army Special Operations Command
  • Lieutenant Commander David McDonald, Department Head, Transfer Center, Naval Medical Center Camp Lejeune
  • Tony Matcham, Medical Material Requirement Specialist Manager, US Army Special Operations Command
  • Y. Sammy Choi, MD, Chief, Department of Research, Womack Army Medical Center
  • US Army Medical Command (invited)
  • US Army Medical Materiel Agency (invited)
  • Navy Medicine East (invited)

Fort Bragg Research Institute Launch.  The Fort Bragg Research Institute (FBRI) is dedicated to optimizing performance and readiness of the US Army Soldier. Through an endowment created by the Geneva Foundation, FBRI will be able to maximize research collaboration with the Cape Fear Research Consortium and other partner institutions.

Chemical and Biological Defense solutions for our Soldiers: Challenges, Opportunities and Funding Priorities. This session will feature representatives from two critical units of the Department of Defense that are responsible for identifying the priorities in chemical and biological defense  – the Defense Threat Reduction Agency (DTRA) and the Joint Program Executive Office (JPEO).  Each of these organizations have offices that focus on Chemical and Biological Defense (CBD) with DTRA identifying and supporting promising earlier stage technologies and the JPEO – CBD office focused on advanced development of these technologies as they move closer to the market. Also on the panel will be two representative companies – one large and one smaller – that are addressing these critical problems with their skills, expertise and technology solutions through current or past support from DTRA and/or  the JPEO.

  • Mike Stebbins, Director of Operations, Medical CBRN Defense Consortium
  • Dr. Ronald Hann, Jr., Director, Chemical/Biological Technologies Department, Defense Threat Reduction Agency Chemical Biological Technologies and head of the Joint Science and Technology Office for Chemical and Biological Defense, DoD Chemical and Biological Defense Program. Biography.
  • David Williams, Senior Medical Portfolio/Acquisition Manager, Joint Program Executive Office for Chemical and Biological Defense- Chemical and Biological Defense 
  • Willy Valdivia-Granda, CEO, Orion Integrated Biosciences

Marketing and Selling Your Products and Services to the Department of Defense; Department of Veterans Affairs and Department of Health and Human Services. Representatives of the Department of Defense (including Defense Logistics Agency), Department of Veterans Affairs and Department of Health and Human Services will identify current and future requirements, needs and acquisition processes for medical supplies, equipment, devices, services and research and development. These agencies will outline the processes they use to acquire products and services, including the use of prime vendors, GSA schedules, Governmentwide Acquisition Contracts (GWACs) and commercial contracts. They will also discuss opportunities to partner with industry to meet their requirements and serve military populations. 

  • Fran Perez-Wilhite, MBA, North Carolina Military Business Center and Department of Veterans Affairs Appointee, Research Advisory Committee on Gulf War Veterans’ Illnesses
  • Defense Health Agency (invited)
  • David Johns, Director, Medical Supplier Operations at Defense Logistics Agency
  • Joe Larsen, Director (Acting), Division of CBRN Medical Countermeasures, Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response, US Department of Health and Human Services. Biography
  • Thomas J. Leney, Executive Director, Small and Veteran Business Programs, US Department of Veterans Affairs. Biography.

Technology Solutions in Military Medicine:  Augmented Reality for Surgical Telestration and Combat Casualty Care.  As our military faces unprecedented challenges in ever more complex, multi-domain battlefields, significant advances in medical technologies and support in combat casualty care for our soldiers is needed to address serious medical tasks in these complex environments. Modern military medicine requires personnel to integrate and process a tremendous amount of asynchronous information in constantly changing environments (e.g., field hospitals, military treatment facilities [MTFs]). The ability to render medical care whenever and wherever a Service member is called to duty is a requirement for individuals working in the Military Health System (MHS). The field of medical simulation and training continues to be a priority and potential solution for our military partners. This session will focus on a real world example of how the fusion novel technologies are advancing that technology closer to practice and field use.

  • Jerry Heneghan, MBA, Director, UNC Center of Pharmacy Simulation and Chief Design Officer, BioMojo LLC
  • Geoff Miller, Research Scientist, Lab Lead, Medical Modeling & Simulation Innovation Center (MMSIC), Telemedicine & Advanced Technology Research Center (TATRC)
  • Lieutenant Colonel Stephen M. DeLellis MPAS, PA-C, Deputy Surgeon, US Army Special Operations Command

Marketing and Selling Your Product and Services to the Prime Vendors: Partnerships and Subcontracting Opportunities.  Prime vendors to the Department of Defense (including Defense Logistics Agency), Department of Veterans Affairs and Department of Health and Human Services will provide remarks on experiences and realities of doing business with the government agencies.  They will discuss the agencies respective medical prime vendor systems, their experiences in doing businesses with these agencies and their process for leveraging subcontractors (including utilization of DLA Distribution and Pricing Registration Agreement [DAPA] holders) and their SDVOSB partners.  North Carolina product providers and manufacturers will also provide remarks regarding their experiences in supplying the Department of Defense and other federal agencies.  Businesses with the capability to provide subcontractor support should participate in this interactive session. 

  • Beverly Kuykendall, President, Government Business, American Medical Depot (AMD)
  • Richard Webb, Director, Government Accounts, Owens & Minor
  • Corey Russ, CEO, Combat Medical 
  • Samantha Godfrey, President and CEO, United Drug Supply, Inc. WOSB

Networking with Military, Federal Agency and Prime Vendors.  A list will be available closer to the event. 

 





The NC Military Business Center, the NC Community College System, and the State of North Carolina do not officially endorse events. These items are posted strictly for the information and convenience of NCMBC customers.

website by Biz Tools One